RTI Surgical Inc (RTIX) Shares Bought by ClariVest Asset Management LLC

Share on StockTwits

ClariVest Asset Management LLC increased its stake in RTI Surgical Inc (NASDAQ:RTIX) by 20.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,697 shares of the medical equipment provider’s stock after acquiring an additional 11,486 shares during the period. ClariVest Asset Management LLC owned approximately 0.11% of RTI Surgical worth $311,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of RTIX. MetLife Investment Advisors LLC boosted its holdings in RTI Surgical by 245.9% during the first quarter. MetLife Investment Advisors LLC now owns 28,338 shares of the medical equipment provider’s stock worth $130,000 after buying an additional 20,146 shares in the last quarter. Citadel Advisors LLC bought a new stake in RTI Surgical during the first quarter worth approximately $130,000. Mackay Shields LLC bought a new stake in RTI Surgical during the first quarter worth approximately $151,000. JPMorgan Chase & Co. boosted its holdings in RTI Surgical by 204.0% during the first quarter. JPMorgan Chase & Co. now owns 44,163 shares of the medical equipment provider’s stock worth $204,000 after buying an additional 29,634 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its holdings in RTI Surgical by 16.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 125,900 shares of the medical equipment provider’s stock worth $580,000 after buying an additional 17,600 shares in the last quarter. Institutional investors and hedge funds own 68.72% of the company’s stock.

NASDAQ:RTIX traded down $0.05 during trading hours on Friday, reaching $4.40. 78,462 shares of the company’s stock were exchanged, compared to its average volume of 121,065. RTI Surgical Inc has a 12 month low of $3.85 and a 12 month high of $5.10. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.55 and a current ratio of 3.86. The stock has a market capitalization of $275.69 million, a price-to-earnings ratio of 54.38 and a beta of 1.44.

RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings data on Thursday, August 2nd. The medical equipment provider reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. RTI Surgical had a net margin of 1.23% and a return on equity of 3.04%. The firm had revenue of $70.69 million during the quarter, compared to analyst estimates of $70.09 million. sell-side analysts expect that RTI Surgical Inc will post 0.11 EPS for the current fiscal year.

RTIX has been the subject of a number of research reports. ValuEngine upgraded shares of RTI Surgical from a “hold” rating to a “buy” rating in a report on Monday, July 2nd. BidaskClub cut shares of RTI Surgical from a “hold” rating to a “sell” rating in a report on Wednesday, September 5th. Finally, Zacks Investment Research upgraded shares of RTI Surgical from a “hold” rating to a “buy” rating and set a $5.25 target price for the company in a report on Tuesday, August 7th.

RTI Surgical Company Profile

RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

See Also: Market Capitalization in the Stock Market

Institutional Ownership by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.